Waters CEO Highlights China's Role in Biopharma Innovation
Waters CEO Udit Batra emphasized China's growing influence as a source of biopharmaceutical innovation, noting strong growth in the region. Waters reported better-than-expected earnings and revenue, driven by a 14% increase in its pharmaceutical segment and nearly 30% growth in Asia. The company's performance reflects a broader shift in China's pharma market, where innovation is driving expansion.
Topics: Biotech China Earnings Global Market Trends Pharmaceuticals